4/A: Koru Medical Systems Director Amends SEC Filing to Correct Share Ownership

A Koru Medical Systems director amended a previous SEC filing to correct the number of shares beneficially owned following a transaction.

Summary

• Robert Cascella, a director at Koru Medical Systems, filed an amendment to a previous SEC Form 4.
• The amendment corrects a typographical error in the original filing regarding the number of shares beneficially owned after a transaction on October 1, 2024.
• The corrected number of shares beneficially owned is 70,619, down from the previously reported 70,978.
• The transaction involved the acquisition of 5,454 shares at a price of $2.75 per share.

Sentiment

Score: 7

Explanation: The document is a routine correction of a previous filing, indicating no significant positive or negative sentiment. It is a neutral event.

Industry Context

This is a routine filing related to insider trading and is not indicative of any broader industry trends.

Comparison to Industry Standards

• Form 4 filings are standard practice for company insiders and directors, and this amendment is a correction of a previous filing, which is not unusual.
• The transaction itself is a standard purchase of shares by a director, which is common among publicly traded companies.

Stakeholder Impact

• The correction of the filing ensures transparency for shareholders regarding insider transactions.

Key Dates

Keywords

SEC Filing, Beneficial Ownership, Koru Medical Systems, Director, Share Transaction, Form 4, Amendment